ArticleDiscover nano2026
Silica nanoparticles antagonize while titania nanoparticles synergize silver nanoparticle toxicity in zebrafish.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study investigated the individual and combined toxicity of silver (AgNPs), titanium dioxide (TiO₂NPs), and silicon dioxide nanoparticles (SiO₂NPs) in zebrafish (Danio rerio), with emphasis on acute/chronic mortality, oxidative stress, bioaccumulation, and histopathology. In vitro stability tests showed that SiO₂NPs reduced AgNP stability more strongly than TiO₂NPs, leading to greater sedimentation and a lower silver concentration in the water. In vivo acute toxicity assays revealed that SiO₂NPs antagonized, whereas TiO₂NPs synergized, AgNPs-induced lethality. During chronic exposure, the highest whole-body Ag accumulation occurred in fish co-exposed to AgNPs and SiO₂NPs. Notably, artificial neural network modeling predicted a late-phase decline in whole-body silver burden during the uptake phase, particularly in the AgNPs-H + SiO₂NPs treatment, although this prediction did not constitute direct evidence of active excretion. During chronic exposure, both SiO₂NPs and TiO₂NPs reduced AgNP-associated mortality, but their effects on tissue damage and oxidative stress were divergent: AgNPs + TiO₂NPs exacerbated liver damage and suppressed antioxidant defenses, whereas AgNPs + SiO₂NPs attenuated gill and intestinal damage and enhanced antioxidant responses. Our results underscore that co-exposure to nanoparticles can fundamentally alter their stability, bioavailability, and toxicological outcomes, with effects ranging from antagonistic to synergistic depending on the nanoparticle combination and target organ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.